Published in Clinical Oncology Week, April 19th, 2004
Physicians have long assumed that early follow-up scans for residual or recurrent thyroid cancer are only possible when patients have been through 6 weeks of a weaker thyroid medication and 2-3 weeks of no thyroid medication.
Withdrawal from medication leads patients' bodies to produce their own thyroid-stimulating hormone (TSH), and exposure to sufficiently high levels of TSH creates...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.